Unresolved issues in prophylaxis

Haemophilia

Volumn 8, Issue 6, 2002, Pages 817-821

  Brown, S A ^a   Aledort, L M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTHROPATHY; CATHETER INFECTION; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FUNGUS; GRAM NEGATIVE BACTERIUM; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMMUNOLOGICAL TOLERANCE; MEDICAL LITERATURE; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SCORING SYSTEM; THROMBOSIS; VASCULAR ACCESS;

EID: 0036861198     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2002.00685.x     Document Type: Conference Paper

References (10)

1. Ljung RCR. Prophylactic treatment in Sweden - overtreatment or optimal model? Haemophilia 1998; 4: 409-12.
2. Tusell J, Perez-Bianco R. Prophylaxis in the developed and in emerging countries. Haemophilia 2002; 8: 183-8.
3. Nilsson IM, Berntorp, E, Lofqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Int Med 1992; 232: 25-32.
4. Aledort LM, Haschemeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Int Med 1994; 236: 391-9.
5. Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp, E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-13.
6. Fischer K, van der Bom JG, Mauser-Bunschoten EP et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002; 99: 2337-41.
7. Schramm W. Experience with prophylaxis in Germany. Semin Hematol 1993; 30 (3; Suppl. 2): 12-5.
8. Brown SA, Aledort LM, Lee CA et al. Optimal treatment regimens for patients with bleeding disorders. Haemophilia 2001; 7: 1113-20.
9. Carlsson M, Berntorp E, Bjorkman S, Lindvall K. Pharmacokinetic dosing in prophylactic treatment of hemophilia A. Eur J Haematol 1993; 51: 247-52.
10. Nuss R, Kilcoyne RF, Geraghty S et al. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 2000; 6: 162-9.